127 related articles for article (PubMed ID: 3513562)
21. Rituximab, cyclophosphamide-fractionated, vincristine, doxorubicin and dexamethasone alternating with rituximab, methotrexate and cytarabine overcomes risk features associated with inferior outcomes in treatment of newly diagnosed, high-risk diffuse large B-cell lymphoma.
Mato A; Feldman T; Zielonka T; Singavi A; Gadaletta G; Waksmundzki K; Bhattacharyya P; Chow KF; Yang X; Panush D; Agress H; Rosario M; Howlett C; Pecora A; Goy A
Leuk Lymphoma; 2013 Dec; 54(12):2606-12. PubMed ID: 23488604
[TBL] [Abstract][Full Text] [Related]
22. Transient congenital dilated cardiomyopathy after maternal R-CHOP chemotherapy during pregnancy.
Padberg S; Mick I; Frenzel C; Greil R; Hilberath J; Schaefer C
Reprod Toxicol; 2017 Aug; 71():146-149. PubMed ID: 28552383
[TBL] [Abstract][Full Text] [Related]
23. A case of angiotropic large cell lymphoma manifesting nephrotic syndrome and treated successfully with combination chemotherapy.
Nishikawa K; Sekiyama S; Suzuki T; Ito Y; Matsukawa W; Tamai H; Yoshida F; Fukatsu A; Matsuo S; Shigematsu H
Nephron; 1991; 58(4):479-82. PubMed ID: 1922616
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of diffuse large B-cell lymphosarcoma with involvement of bone marrow in an old female patient].
Zamiatina VI; Kravchenko SK; Giliazitdinova EA; Magomedova AU; Vorob'ev IA; Gotman LN; Kaplanskaia IB; Kesel'man SA; Obukhova TN; Sakhibov IaD; Shevelev AA; Kremenetskaia AM
Ter Arkh; 2008; 80(7):54-7. PubMed ID: 18763597
[No Abstract] [Full Text] [Related]
25. Long-term follow-up of dose-adjusted EPOCH plus rituximab (DA-EPOCH-R) in untreated patients with poor prognosis large B-cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group.
Purroy N; Bergua J; Gallur L; Prieto J; Lopez LA; Sancho JM; García-Marco JA; Castellví J; Montes-Moreno S; Batlle A; de Villambrosia SG; Carnicero F; Ferrando-Lamana L; Piris MA; Lopez A
Br J Haematol; 2015 Apr; 169(2):188-98. PubMed ID: 25521006
[TBL] [Abstract][Full Text] [Related]
26. Nonpegylated Liposomal Doxorubicin as a Component of R-CHOP Is an Effective and Safe Alternative to Conventional Doxorubicin in the Treatment of Patients With Diffuse Large B-Cell Lymphoma and Preexisting Cardiac Diseases.
Rohlfing S; Aurich M; Schöning T; Ho AD; Witzens-Harig M
Clin Lymphoma Myeloma Leuk; 2015 Aug; 15(8):458-63. PubMed ID: 25899891
[TBL] [Abstract][Full Text] [Related]
27. [A case report of composite lymphoma].
Wu J; Wang ZC; Chen XD
Ai Zheng; 2007 Apr; 26(4):447. PubMed ID: 17430672
[No Abstract] [Full Text] [Related]
28. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma.
Gordon LI; Harrington D; Andersen J; Colgan J; Glick J; Neiman R; Mann R; Resnick GD; Barcos M; Gottlieb A
N Engl J Med; 1992 Nov; 327(19):1342-9. PubMed ID: 1383819
[TBL] [Abstract][Full Text] [Related]
29. Lymphoma with massive cardiac involvement.
Flores Umanzor EJ; Caldentey Adrover G; Rodriguez Londres J; San Antonio R; Diaz Mejía NM
Acta Cardiol; 2016; 71(5):621-622. PubMed ID: 27695024
[No Abstract] [Full Text] [Related]
30. Impact of occult bone marrow involvement on the outcome of rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone therapy for diffuse large B-cell lymphoma.
Arima H; Maruoka H; Nasu K; Tabata S; Kurata M; Matsushita A; Imai Y; Takahashi T; Ishikawa T
Leuk Lymphoma; 2013 Dec; 54(12):2645-53. PubMed ID: 23566159
[TBL] [Abstract][Full Text] [Related]
31. Non-Hodgkin's lymphoma (diffuse large B cell lymphoma).
Copson E
Clin Evid; 2006 Jun; (15):30-44. PubMed ID: 16973004
[No Abstract] [Full Text] [Related]
32. The Clinical and Hormonal Characteristics of Primary Adrenal Lymphomas: The Necessity of Early Detection of Adrenal Insufficiency.
Harada K; Kimura K; Iwamuro M; Terasaka T; Hanayama Y; Kondo E; Hayashi E; Yoshino T; Otsuka F
Intern Med; 2017 Sep; 56(17):2261-2269. PubMed ID: 28794358
[TBL] [Abstract][Full Text] [Related]
33. Diffuse large B-cell lymphoma resembling a metastatic liver tumour.
Saitoh Y; Gotoh M; Katagiri S; Ohyashiki K
Br J Haematol; 2015 Jan; 168(1):1. PubMed ID: 25312576
[No Abstract] [Full Text] [Related]
34. Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphoma.
Furman RR; Martin P; Ruan J; Cheung YK; Vose JM; LaCasce AS; Elstrom R; Coleman M; Leonard JP
Cancer; 2010 Dec; 116(23):5432-9. PubMed ID: 20665890
[TBL] [Abstract][Full Text] [Related]
35. Increased rituximab (R) doses eliminate increased risk and improve outcome of elderly male patients with aggressive CD20+ B-cell lymphomas: the SEXIE-R-CHOP-14 trial of the DSHNHL.
Clin Adv Hematol Oncol; 2014 Aug; 12(8 Suppl 16):8-9. PubMed ID: 25768993
[No Abstract] [Full Text] [Related]
36. [Efficacy of chemotherapy in extremely elderly patients with diffuse large B-cell lymphoma].
Takahashi A; Mishima Y; Yokoyama M; Inoue N; Kusano Y; Gunji T; Nitta H; Ueda K; Nishimura N; Tsuyama N; Takeuchi K; Terui Y; Hatake K
Rinsho Ketsueki; 2017; 58(5):427-432. PubMed ID: 28592754
[TBL] [Abstract][Full Text] [Related]
37. Targeting drug resistance to close the gap in diffuse large B-cell lymphoma.
Rund D
Leuk Lymphoma; 2014 Sep; 55(9):1966-7. PubMed ID: 24588736
[No Abstract] [Full Text] [Related]
38. A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma.
Micallef IN; Kahl BS; Maurer MJ; Dogan A; Ansell SM; Colgan JP; Geyer S; Inwards DJ; White WL; Habermann TM
Cancer; 2006 Dec; 107(12):2826-32. PubMed ID: 17099879
[TBL] [Abstract][Full Text] [Related]
39. Long-term remission of paroxysmal nocturnal hemoglobinuria following chemoimmunotherapy for non-Hodgkin lymphoma.
Lai S; Venugopal P; Leslie W
Clin Adv Hematol Oncol; 2012 Feb; 10(2):134-6. PubMed ID: 22402359
[No Abstract] [Full Text] [Related]
40. [Intravascular large B-cell lymphoma: report of a case].
Yu GH; Qu GM; Yao WD; Lang ZQ; Wang W
Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):488-9. PubMed ID: 19781202
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
